# RIGEL PHARMACEUTICALS INC (RIGL)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/RIGL/

- Reporting holders: 6
- Reported value: $637.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Venture Visionary Partners LLC](https://holderbook.com/funds/1792283-venture-visionary-partners-llc/) | $296.1K | 6,150 | 0.0% | 1 |
| [JUNCTURE WEALTH STRATEGIES, LLC](https://holderbook.com/funds/1632866-juncture-wealth-strategies-llc/) | $219.6K | 4,561 | 0.1% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $48.4K | 1,006 | 0.0% | 2 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $45.5K | 945 | 0.0% | 9 |
| [GK Wealth Management LLC](https://holderbook.com/funds/2069222-gk-wealth-management-llc/) | $14.9K | 310 | 0.0% | 1 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $12.8K | 266 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 6 | $637.4K |
| Q2 2026 | 159 | $699.3M |
| Q1 2026 | 150 | $434.6M |
| Q4 2025 | 185 | $698.6M |
| Q3 2025 | 165 | $430.0M |
| Q2 2025 | 125 | $261.7M |
| Q1 2025 | 121 | $252.7M |
| Q4 2024 | 117 | $204.3M |
| Q3 2024 | 93 | $203.1M |
| Q2 2024 | 84 | $93.4M |
| Q1 2024 | 2 | $271.2K |
| Q4 2023 | 2 | $478.9K |